HERPES ZOSTER
Clinical trials for HERPES ZOSTER explained in plain language.
Never miss a new study
Get alerted when new HERPES ZOSTER trials appear
Sign up with your email to follow new studies for HERPES ZOSTER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA tech takes aim at painful shingles
⭐️ VACCINE ⭐️ Not yet recruitingThis study is testing a new shingles vaccine that uses mRNA technology. It aims to see if the vaccine is safe and how well it triggers the body's immune defenses in healthy adults aged 50 to 79. The new vaccine will be compared directly to an already approved shingles vaccine.
Matched conditions: HERPES ZOSTER
Phase: PHASE2 • Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:35 UTC
-
New mRNA tech takes aim at painful shingles
⭐️ VACCINE ⭐️ Not yet recruitingThis study is testing a new mRNA vaccine, called SYS6017, designed to prevent shingles. It will involve 800 healthy adults aged 40 and older to see how well their immune systems respond and to check for side effects. The new vaccine will be compared against a placebo (a shot with…
Matched conditions: HERPES ZOSTER
Phase: PHASE2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 18, 2026 14:42 UTC